A Randomized Controlled Trial of Methotrexate and Cyclosporine in the Treatment of Psoriasis

Archives of Dermatology

Volumn 140, Issue 3, 2004, Pages 347-348

  Bigby, Michael ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; METHOTREXATE;

CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; HUMAN; NOTE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PSORIASIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REMISSION; RISK ASSESSMENT; ULTRAVIOLET B RADIATION;

ADOLESCENT; ADULT; CYCLOSPORINE; DERMATOLOGIC AGENTS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; METHOTREXATE; MULTICENTER STUDIES; NETHERLANDS; PSORIASIS; RANDOMIZED CONTROLLED TRIALS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 1542724640     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.140.3.347     Document Type: Note

References (5)

1. Juni P, Altman DG, Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ. 2001;323:42-46.
2. van Ede AE, Laan RFM, Rood MJ, et al. Effect of folic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum. 2001;44:1515-1524.
3. Spuls PI, Witkamp L, Bossuyt PM, Bos JD. A systematic review of five systemic treatments for severe psoriasis. Br J Dermatol. 1997;137:943-949.
4. Griffiths CE, Clark CM, Chalmers RJ, Li Wan Po A, Williams HC. A systematic review of treatments of severe psoriasis. Health Technol Assess. 2000;4:1-125.
5. Chalmers RJG. Psoriasis. In: Williams HC, Bigby M, Diepgen T, Herxheimer A, Naldi L, Rzany B, eds. Evidence-based Dermatology. London, England: BMJ Books; 2003:226-252.